Concepts (180)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Pulmonary Embolism | 10 | 2021 | 4775 | 0.79 | Why? |
| Pulmonary Artery | 2 | 2018 | 803 | 0.56 | Why? |
| Arterial Occlusive Diseases | 2 | 2018 | 363 | 0.56 | Why? |
| Fibrinogen | 1 | 2018 | 1048 | 0.49 | Why? |
| Venous Thromboembolism | 8 | 2021 | 4273 | 0.36 | Why? |
| Neoplasms, Unknown Primary | 2 | 2018 | 28 | 0.36 | Why? |
| Endothelial Progenitor Cells | 2 | 2020 | 103 | 0.35 | Why? |
| von Willebrand Factor | 2 | 2021 | 668 | 0.28 | Why? |
| France | 8 | 2021 | 12074 | 0.22 | Why? |
| Heart, Artificial | 1 | 2020 | 35 | 0.22 | Why? |
| Ventricular Dysfunction, Right | 2 | 2019 | 639 | 0.22 | Why? |
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2020 | 66 | 0.21 | Why? |
| Antigens, CD19 | 1 | 2020 | 98 | 0.21 | Why? |
| Angiopoietin-2 | 1 | 2020 | 125 | 0.19 | Why? |
| Tachycardia | 1 | 2020 | 239 | 0.19 | Why? |
| Chest Pain | 2 | 2020 | 578 | 0.19 | Why? |
| Lupus Coagulation Inhibitor | 1 | 2021 | 262 | 0.19 | Why? |
| Thrombophilia | 2 | 2021 | 1935 | 0.18 | Why? |
| Endoglin | 1 | 2017 | 16 | 0.18 | Why? |
| Anticoagulants | 6 | 2021 | 9563 | 0.17 | Why? |
| ADAMTS13 Protein | 1 | 2021 | 363 | 0.17 | Why? |
| Pulmonary Veins | 1 | 2018 | 146 | 0.17 | Why? |
| Diagnostic Equipment | 1 | 2017 | 41 | 0.17 | Why? |
| Vascular Endothelial Growth Factor A | 1 | 2021 | 604 | 0.16 | Why? |
| Neuroprotection | 1 | 2016 | 62 | 0.16 | Why? |
| Neovascularization, Physiologic | 1 | 2017 | 160 | 0.16 | Why? |
| Fibrin Fibrinogen Degradation Products | 3 | 2021 | 5993 | 0.15 | Why? |
| Immune Sera | 1 | 2020 | 884 | 0.15 | Why? |
| Fluorodeoxyglucose F18 | 3 | 2018 | 1153 | 0.15 | Why? |
| Positron-Emission Tomography | 2 | 2017 | 802 | 0.14 | Why? |
| Endothelium, Vascular | 3 | 2021 | 1751 | 0.14 | Why? |
| Hypothermia, Induced | 1 | 2016 | 176 | 0.14 | Why? |
| Respiratory Sounds | 1 | 2017 | 294 | 0.13 | Why? |
| Combined Modality Therapy | 2 | 2020 | 3395 | 0.13 | Why? |
| Computed Tomography Angiography | 2 | 2020 | 2153 | 0.13 | Why? |
| Status Epilepticus | 1 | 2016 | 303 | 0.12 | Why? |
| Death, Sudden, Cardiac | 1 | 2017 | 522 | 0.11 | Why? |
| Airway Extubation | 1 | 2017 | 403 | 0.11 | Why? |
| Paris | 3 | 2021 | 1287 | 0.11 | Why? |
| Anticonvulsants | 1 | 2016 | 634 | 0.11 | Why? |
| Multivariate Analysis | 2 | 2018 | 5440 | 0.10 | Why? |
| Muscle, Skeletal | 1 | 2017 | 915 | 0.10 | Why? |
| Early Detection of Cancer | 2 | 2018 | 1956 | 0.10 | Why? |
| Middle Aged | 23 | 2021 | 270681 | 0.10 | Why? |
| Aged | 20 | 2021 | 215776 | 0.10 | Why? |
| Ischemia | 1 | 2017 | 901 | 0.10 | Why? |
| Positron Emission Tomography Computed Tomography | 1 | 2018 | 1458 | 0.09 | Why? |
| Lymphopenia | 1 | 2020 | 2669 | 0.09 | Why? |
| Delayed Diagnosis | 1 | 2018 | 1529 | 0.09 | Why? |
| Male | 26 | 2021 | 367725 | 0.09 | Why? |
| Prospective Studies | 8 | 2021 | 43301 | 0.09 | Why? |
| Recurrence | 4 | 2018 | 3675 | 0.09 | Why? |
| Thromboembolism | 1 | 2021 | 2101 | 0.09 | Why? |
| Gene Expression Regulation | 1 | 2020 | 4020 | 0.09 | Why? |
| Female | 25 | 2021 | 380317 | 0.09 | Why? |
| Proportional Hazards Models | 4 | 2021 | 6543 | 0.08 | Why? |
| Kaplan-Meier Estimate | 3 | 2021 | 4260 | 0.08 | Why? |
| Symptom Assessment | 1 | 2020 | 4967 | 0.08 | Why? |
| Biomarkers | 5 | 2021 | 23361 | 0.08 | Why? |
| Hospital Mortality | 8 | 2021 | 22087 | 0.08 | Why? |
| Prognosis | 8 | 2021 | 32490 | 0.08 | Why? |
| Mesenchymal Stem Cell Transplantation | 1 | 2017 | 1322 | 0.07 | Why? |
| B-Lymphocytes | 1 | 2020 | 4418 | 0.07 | Why? |
| Tomography, X-Ray Computed | 4 | 2020 | 25144 | 0.07 | Why? |
| Intensive Care Units | 3 | 2021 | 29594 | 0.07 | Why? |
| Prevalence | 3 | 2021 | 25773 | 0.07 | Why? |
| Communicable Diseases | 1 | 2019 | 2148 | 0.07 | Why? |
| Logistic Models | 1 | 2018 | 9089 | 0.06 | Why? |
| Cardiopulmonary Resuscitation | 1 | 2017 | 1876 | 0.06 | Why? |
| ROC Curve | 3 | 2021 | 6024 | 0.06 | Why? |
| Respiration, Artificial | 4 | 2020 | 22116 | 0.06 | Why? |
| Education, Medical | 1 | 2019 | 2461 | 0.06 | Why? |
| Case-Control Studies | 1 | 2020 | 17671 | 0.06 | Why? |
| Humans | 27 | 2021 | 930598 | 0.06 | Why? |
| Placenta Growth Factor | 1 | 2021 | 93 | 0.05 | Why? |
| E-Selectin | 1 | 2020 | 55 | 0.05 | Why? |
| Molecular Weight | 1 | 2021 | 249 | 0.05 | Why? |
| Adult | 12 | 2021 | 244371 | 0.05 | Why? |
| Extracorporeal Membrane Oxygenation | 1 | 2018 | 5002 | 0.05 | Why? |
| Collagen | 1 | 2021 | 222 | 0.05 | Why? |
| Patient Admission | 3 | 2021 | 5250 | 0.05 | Why? |
| Natriuretic Peptides | 1 | 2019 | 66 | 0.05 | Why? |
| Embolectomy | 1 | 2018 | 101 | 0.05 | Why? |
| Dilatation, Pathologic | 1 | 2017 | 78 | 0.04 | Why? |
| Hindlimb | 1 | 2017 | 21 | 0.04 | Why? |
| Adipogenesis | 1 | 2017 | 38 | 0.04 | Why? |
| Chondrogenesis | 1 | 2017 | 19 | 0.04 | Why? |
| Glasgow Outcome Scale | 1 | 2016 | 56 | 0.04 | Why? |
| Blood Coagulation | 2 | 2021 | 2768 | 0.04 | Why? |
| Early Medical Intervention | 1 | 2021 | 487 | 0.04 | Why? |
| Perfusion | 1 | 2018 | 254 | 0.04 | Why? |
| Cell Adhesion | 1 | 2017 | 230 | 0.04 | Why? |
| Retrospective Studies | 4 | 2021 | 105322 | 0.04 | Why? |
| Regional Blood Flow | 1 | 2017 | 172 | 0.04 | Why? |
| Mice, Nude | 1 | 2017 | 340 | 0.04 | Why? |
| Watchful Waiting | 1 | 2018 | 276 | 0.04 | Why? |
| Patients' Rooms | 1 | 2021 | 675 | 0.04 | Why? |
| Hemoptysis | 1 | 2018 | 172 | 0.04 | Why? |
| Quality-Adjusted Life Years | 1 | 2018 | 511 | 0.04 | Why? |
| Survival Rate | 2 | 2021 | 9206 | 0.04 | Why? |
| Blood Component Transfusion | 1 | 2020 | 740 | 0.04 | Why? |
| Severity of Illness Index | 5 | 2021 | 48226 | 0.04 | Why? |
| Protein Multimerization | 1 | 2021 | 1336 | 0.04 | Why? |
| Echocardiography | 2 | 2019 | 3661 | 0.03 | Why? |
| Protective Factors | 1 | 2021 | 1720 | 0.03 | Why? |
| Necrosis | 1 | 2017 | 532 | 0.03 | Why? |
| Transfection | 1 | 2017 | 864 | 0.03 | Why? |
| Multidetector Computed Tomography | 1 | 2017 | 307 | 0.03 | Why? |
| RNA Interference | 1 | 2017 | 534 | 0.03 | Why? |
| Awareness | 1 | 2019 | 529 | 0.03 | Why? |
| Hemostasis | 1 | 2020 | 811 | 0.03 | Why? |
| Area Under Curve | 1 | 2021 | 2564 | 0.03 | Why? |
| Warfarin | 1 | 2018 | 402 | 0.03 | Why? |
| Venous Thrombosis | 2 | 2018 | 2739 | 0.03 | Why? |
| Antibodies, Antiphospholipid | 1 | 2018 | 519 | 0.03 | Why? |
| Troponin | 1 | 2019 | 1058 | 0.03 | Why? |
| Ontario | 1 | 2018 | 1966 | 0.03 | Why? |
| Schools, Medical | 1 | 2019 | 793 | 0.03 | Why? |
| Belgium | 1 | 2017 | 2064 | 0.03 | Why? |
| Body Temperature | 1 | 2016 | 875 | 0.03 | Why? |
| Diagnostic Imaging | 1 | 2018 | 1044 | 0.03 | Why? |
| Respiratory Function Tests | 1 | 2017 | 1755 | 0.02 | Why? |
| Switzerland | 1 | 2017 | 2738 | 0.02 | Why? |
| Endothelial Cells | 1 | 2020 | 2048 | 0.02 | Why? |
| Aged, 80 and over | 4 | 2021 | 88759 | 0.02 | Why? |
| Electroencephalography | 1 | 2016 | 1242 | 0.02 | Why? |
| Follow-Up Studies | 2 | 2018 | 17020 | 0.02 | Why? |
| Proteomics | 1 | 2020 | 2481 | 0.02 | Why? |
| Hemodynamics | 1 | 2017 | 1562 | 0.02 | Why? |
| Gene Expression Profiling | 1 | 2020 | 3788 | 0.02 | Why? |
| Cost-Benefit Analysis | 1 | 2018 | 2259 | 0.02 | Why? |
| Hospitalization | 4 | 2021 | 54280 | 0.02 | Why? |
| Neoplasms | 1 | 2017 | 17251 | 0.02 | Why? |
| Antibodies, Viral | 1 | 2020 | 51949 | 0.02 | Why? |
| Electronic Health Records | 1 | 2021 | 3492 | 0.02 | Why? |
| Hematologic Neoplasms | 1 | 2020 | 2105 | 0.02 | Why? |
| Recovery of Function | 1 | 2017 | 2461 | 0.02 | Why? |
| Blood Coagulation Disorders | 1 | 2020 | 2040 | 0.02 | Why? |
| Double-Blind Method | 1 | 2018 | 5988 | 0.02 | Why? |
| Pandemics | 4 | 2021 | 389249 | 0.02 | Why? |
| Phenotype | 1 | 2017 | 4037 | 0.02 | Why? |
| Cells, Cultured | 1 | 2017 | 5835 | 0.02 | Why? |
| Acute Disease | 1 | 2019 | 6029 | 0.02 | Why? |
| Risk Factors | 3 | 2021 | 71621 | 0.02 | Why? |
| Thrombolytic Therapy | 1 | 2017 | 2218 | 0.02 | Why? |
| Curriculum | 1 | 2019 | 3083 | 0.02 | Why? |
| Dyspnea | 1 | 2018 | 3847 | 0.02 | Why? |
| Protein Binding | 1 | 2021 | 11430 | 0.02 | Why? |
| Immunization, Passive | 1 | 2020 | 10067 | 0.02 | Why? |
| Risk Assessment | 2 | 2019 | 25439 | 0.02 | Why? |
| Angiotensin Receptor Antagonists | 1 | 2020 | 3892 | 0.02 | Why? |
| Time Factors | 2 | 2017 | 31397 | 0.02 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.02 | Why? |
| Cross-Sectional Studies | 2 | 2021 | 53120 | 0.02 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 5277 | 0.01 | Why? |
| Europe | 1 | 2019 | 12702 | 0.01 | Why? |
| Research Design | 1 | 2018 | 5830 | 0.01 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.01 | Why? |
| Hospitals | 1 | 2021 | 11793 | 0.01 | Why? |
| Signal Transduction | 1 | 2017 | 7207 | 0.01 | Why? |
| Reproducibility of Results | 1 | 2017 | 11304 | 0.01 | Why? |
| Population Surveillance | 1 | 2017 | 4967 | 0.01 | Why? |
| Patient Acceptance of Health Care | 1 | 2018 | 5002 | 0.01 | Why? |
| Students, Medical | 1 | 2019 | 4032 | 0.01 | Why? |
| Infant, Newborn | 1 | 2021 | 23105 | 0.01 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.01 | Why? |
| Adolescent | 2 | 2021 | 86841 | 0.01 | Why? |
| Disease Models, Animal | 1 | 2017 | 10998 | 0.01 | Why? |
| Young Adult | 2 | 2021 | 93724 | 0.01 | Why? |
| Thrombosis | 1 | 2021 | 7504 | 0.01 | Why? |
| Infant | 1 | 2021 | 30274 | 0.01 | Why? |
| Registries | 1 | 2017 | 12327 | 0.01 | Why? |
| Child, Preschool | 1 | 2021 | 36283 | 0.01 | Why? |
| Critical Care | 1 | 2020 | 14081 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2017 | 22971 | 0.01 | Why? |
| Cardiovascular Diseases | 1 | 2020 | 11497 | 0.01 | Why? |
| Child | 1 | 2021 | 70012 | 0.01 | Why? |
| Treatment Outcome | 1 | 2016 | 51732 | 0.01 | Why? |
| Lung | 1 | 2018 | 31049 | 0.01 | Why? |
| Animals | 1 | 2017 | 78931 | 0.01 | Why? |
Planquette's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(180)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(183)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_